ArticleCureus2024

Poor Prognosis in Low-Grade Endometrial Stromal Sarcoma With Cyclin-Dependent Kinase Inhibitor 2A Homozygous Deletion: A Case Study.

Atsushi Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.